TuHURA BIOSCIENCES, INC./NV Loans Payable, Current
TuHURA BIOSCIENCES, INC./NV (HURA) had Loans Payable, Current of $503.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LoansPayableCurrent · last filed 2021-05-13
- 2021-03-31: Loans Payable, Current $503.00K.
- 2020-12-31: Loans Payable, Current $473.00K.
- 2020-09-30: Loans Payable, Current $441.00K.
- 2013-03-31: Loans Payable, Current $296.06K.
| Period end | Loans Payable, Current | Loans Payable, Current as first filed |
|---|---|---|
| 2021-03-31 | $503.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $473.00K 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $441.00K 10-Q · filed 2020-11-12 | |
| 2013-03-31 | $296.06K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $264.35K 10-K · filed 2014-08-28 | $447.78K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |